Delta Investment Management, LLC Amgen Inc Transaction History

Delta Investment Management, LLC

$433 Million
Q3 2024

A detailed history of Delta Investment Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Delta Investment Management, LLC holds 1,714 shares of AMGN stock, worth $504,824. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,714

Previous 1,903 9.93%

Holding current value

$504,824

Previous $594,000 7.07%

% of portfolio

0.13%

Previous 0.15%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $58,472 - $63,764	-189 Reduced 9.93%	1,714 $552,000
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $16,027 - $19,477	61 Added 3.31%	1,903 $594,000
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $39,255 - $47,385	146 Added 8.61%	1,842 $523,000
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $1,278 - $1,442	5 Added 0.3%	1,696 $488,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $54,443 - $67,593	249 Added 17.27%	1,691 $454,000
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $642 - $760	-3 Reduced 0.21%	1,442 $320,000
Q1 2023 May 05, 2023	SELL	$225.79 - $275.2 $11,741 - $14,310	-52 Reduced 3.47%	1,445 $349,000
Q4 2022 Jan 19, 2023	BUY	$229.03 - $291.01 $43,744 - $55,582	191 Added 14.62%	1,497 $0
Q3 2022 Oct 21, 2022	BUY	$224.46 - $253.15 $293,144 - $330,613	1,306 New	1,306 $294,000
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $196,210 - $252,198	-1,037 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$174.11 - $208.62 $51,362 - $61,542	-295 Reduced 22.15%	1,037 $200,000
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $222,044 - $260,286	1,332 New	1,332 $245,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Investment Management, LLC with notifications on news.

Account

Delta Investment Management, LLC Amgen Inc Transaction History